Symphogen AS - Strategic SWOT Analysis Review

Date: November 29, 2016
Pages: 30
Price:
US$ 300.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: SFB44A161F4EN
Leaflet:

Download PDF Leaflet

Symphogen AS - Strategic SWOT Analysis Review
Symphogen AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Symphogen A/S (Symphogen) develops recombinant antibody mixtures, which can be used in the production of next-generation antibody therapeutics for the treatment of cancer, infectious and autoimmune diseases. It develops antibody therapeutics based on its three proprietary technology platforms such as Symplex discovery, SymSelect functional and Sympress technology. Symphogen’s product pipeline includes Sym004, for the treatment of head, neck and colorectal cancer; Sym013, a mixture of six humanized monoclonal antibodies for the treatment of cancer; and Sym015, against receptor tyrosine kinase target and stromal target. The company has operations in the US, Europe and Japan. Symphogen is headquartered in Ballerup, Denmark.

Symphogen AS Key Recent Developments

Sep 14, 2016: Symphogen Names New Chief Financial Officer
Aug 18, 2016: Symphogen’s Founding CEO Kirsten Drejer Steps Down and Becomes Executive Director
May 11, 2016: Symphogen Announces the Appointment of Jeffrey H. Buchalter and Christoffer Soderberg as Non-Executive Directors

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Symphogen A/S - Key Facts
Symphogen A/S - Key Employees
Symphogen A/S - Key Employee Biographies
Symphogen A/S - Major Products and Services
Symphogen A/S - Pharmaceutical Pipeline Products Data
Symphogen A/S, Pipeline Products by Therapy Area
Symphogen A/S, Pipeline Products by Development Phase
Symphogen A/S - History
Symphogen A/S - Company Statement
Symphogen A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Symphogen A/S - Business Description
Symphogen A/S - Corporate Strategy
Symphogen A/S - SWOT Analysis
SWOT Analysis - Overview
Symphogen A/S - Strengths
Symphogen A/S - Weaknesses
Symphogen A/S - Opportunities
Symphogen A/S - Threats
Symphogen A/S - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Symphogen A/S, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Sep 14, 2016: Symphogen Names New Chief Financial Officer
Aug 18, 2016: Symphogen’s Founding CEO Kirsten Drejer Steps Down and Becomes Executive Director
May 11, 2016: Symphogen Announces the Appointment of Jeffrey H. Buchalter and Christoffer Soderberg as Non-Executive Directors

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Symphogen A/S, Key Facts
Symphogen A/S, Key Employees
Symphogen A/S, Key Employee Biographies
Symphogen A/S, Major Products and Services
Symphogen A/S, Number of Pipeline Products by Therapy Area
Symphogen A/S, Number of Pipeline Products by Development Stage
Symphogen A/S, Pipeline Products By Therapy Area and Development Phase
Symphogen A/S, History
Symphogen A/S, Subsidiaries
Symphogen A/S, Key Competitors
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Symphogen A/S, Recent Deals Summary

LIST OF FIGURES

Symphogen A/S, Pipeline Products by Therapy Area
Symphogen A/S, Pipeline Products by Development Phase
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Symphogen A/S, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Zealand Pharma A/S
Roche Innovation Center Copenhagen A/S
Nuevolution A/S
Norpharma A/S
MedAnnex Ltd
Lead Pharma Holding BV
CytoVac A/S
Bifodan A/S
Bavarian Nordic A/S
Affitech A/S
2cureX ApS
Skip to top


Ask Your Question

Symphogen AS - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: